Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases. The company is dedicated to educating ...

Background and Aim: Chronic viral infections such as human immunodeficiency virus and hepatitis C virus (HCV) may decrease tissue response to insulin, thereby causing insulin resistance. In addition, ...

A large portion of the session focused on what the guidelines referred to as the “indeterminate phase” or “grey zone” of CHB, ...

Please provide your email address to receive an email when new articles are posted on . Less than 20% of veterans with chronic HBV completed testing for HDV. Veterans with chronic HBV who were HDV ...

Please provide your email address to receive an email when new articles are posted on . The highest percentages of patients with HBsAg loss were observed in the groups that received xalnesiran plus an ...

Hepatitis B is a serious liver disease caused by the hepatitis B virus (HBV), which is a small DNA virus from the Hepadnaviridae family. If someone has this infection for a long time, it can lead to ...

PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

Assembly Biosciences reported positive Phase 1b results for ABI-4334 in chronic HBV, showing strong antiviral activity and favorable safety. Assembly Biosciences, Inc. has announced positive results ...

Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and ...

The International Agency for Research on Cancer (IARC) of the World Health Organization has classified hepatitis D virus (HDV) as carcinogenic, citing sufficient evidence and placing it alongside ...